1020P Rescue by radiotherapy and anti-CTLA4/PD-1 after failure of anti-PD-1 therapy in metastatic NSCLC patients: The RECLAIM study

Schneiders, Famke L.; Hashemi, S.; Veltman, Joris D.; Daniëls, Hans; Fransen, Marieke F.; Radonic, Teodora; Ulas, Ezgi B.; Houda, Ilias; Barlo, Nicole P.; Disselhorst, M.; Laren, M. van; Tiemessen, M.; Tarasevych, S.; Haarst, J.M.M. van; Tilburg, Peter Van; Kunst, Peter W.A.; Moons-Pasic, A.; Gruijl, Tanja D. de; Senan, Suresh

doi:10.1016/j.annonc.2022.07.1146

Annals of Oncology

2022

DOI: 10.1016/j.annonc.2022.07.1146

|View full text |Cite

1020P Rescue by radiotherapy and anti-CTLA4/PD-1 after failure of anti-PD-1 therapy in metastatic NSCLC patients: The RECLAIM study

Famke L. Schneiders

S. Hashemi

Joris D. Veltman

et al.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2023

Publication Types

Select...

Article1

Relationship

Self Cite0

Independent1

Authors

Journals

Cited by 1 publication

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

What to do after immune-checkpoint inhibitors failure in advanced non-small cell lung cancer: an expert opinion and review

Agostara,

Roazzi,

Villa

et al. 2023

Expert Review of Respiratory Medicine

View full text Add to dashboard Cite

What to do after immune-checkpoint inhibitors failure in advanced non-small cell lung cancer: an expert opinion and review

Agostara,

Roazzi,

Villa

et al. 2023

Expert Review of Respiratory Medicine

View full text Add to dashboard Cite

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

hi@scite.ai

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

1020P Rescue by radiotherapy and anti-CTLA4/PD-1 after failure of anti-PD-1 therapy in metastatic NSCLC patients: The RECLAIM study

Cited by 1 publication

References 0 publications

What to do after immune-checkpoint inhibitors failure in advanced non-small cell lung cancer: an expert opinion and review

What to do after immune-checkpoint inhibitors failure in advanced non-small cell lung cancer: an expert opinion and review

Contact Info

Product

Resources

About